Cytomx Therapeutics Inc (CTMX)

Apr 05, 2026

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Brokerages - marketbeat.com

Apr 05, 2026

Apr 04, 2026

CTMX Technical Analysis & ETF Price Forecast - Intellectia AI

Apr 04, 2026

Apr 03, 2026

CytomX Therapeutics (CTMX) price target increased by 47.30% to 13.90 - MSN

Apr 03, 2026

Apr 03, 2026

CytomX Therapeutics (CTMX) gains analyst confidence on trial progress - msn.com

Apr 03, 2026

Apr 02, 2026

CytomX Therapeutics, Inc. (CTMX) latest stock news and headlines - Yahoo Finance Singapore

Apr 02, 2026

Apr 02, 2026

CTMX Stock Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

Apr 02, 2026

Apr 01, 2026

Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026 - Meyka

Apr 01, 2026

Apr 01, 2026

CytomX Therapeutics Signals Progress in Varseta-M Trial - TipRanks

Apr 01, 2026

Apr 01, 2026

Aug Update: Does CytomX Therapeutics Inc have strong EBITDA marginsTreasury Yields & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

US Market Wrap: Is CytomX Therapeutics Inc a good stock for dollar cost averaging2026 Breakouts & Breakdowns & Weekly Setup with High ROI Potential - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

CTMX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026

Mar 31, 2026

CytomX Therapeutics launches $250M public offering - msn.com

Mar 31, 2026

Mar 31, 2026

CytomX Therapeutics gears up for Q4 print; here are the recent forecast changes from Wall Street's most accurate analysts - MSN

Mar 31, 2026

Mar 30, 2026

Aug Fed Impact: What hedge funds are buying CytomX Therapeutics Inc2026 Short Interest & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

CTMX stock rallies on strong phase I colorectal cancer study data - MSN

Mar 28, 2026

Mar 28, 2026

Performance Recap: Is CytomX Therapeutics Inc stock showing strong momentum2026 Top Gainers & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress - Insider Monkey

Mar 27, 2026

Mar 27, 2026

CytomX Therapeutics (NASDAQ:CTMX) Trading 4.9% HigherShould You Buy? - marketbeat.com

Mar 27, 2026

Mar 27, 2026

Cantor Fitzgerald Initiates Coverage of CytomX Therapeutics (CTMX) with Overweight Recommendation - msn.com

Mar 27, 2026

Mar 27, 2026

CTMX Stock Price, Quote & Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

Mar 27, 2026

Mar 26, 2026

Vanguard (CTMX) reports 0 shares; disaggregation after internal realignment - Stock Titan

Mar 26, 2026

Mar 26, 2026

How The CytomX Therapeutics (CTMX) Narrative Is Shifting With New Colorectal Cancer Data - Yahoo Finance

Mar 26, 2026

Mar 25, 2026

Jefferies Maintains Buy on CytomX Therapeutics, Inc. (CTMX) $16 PT Mar 2026 - Meyka

Mar 25, 2026

Mar 25, 2026

Barclays Maintains CytomX Therapeutics (CTMX) Overweight Recommendation - MSN

Mar 25, 2026

Mar 25, 2026

Jefferies raises CytomX Therapeutics (CTMX) price target to $16 - msn.com

Mar 25, 2026

Mar 24, 2026

CytomX highlights clinical progress for lead cancer drug in Q4 update - MSN

Mar 24, 2026

Mar 24, 2026

Jefferies reiterates Buy rating on CytomX stock after phase 1 data - Investing.com Canada

Mar 24, 2026

Mar 23, 2026

CytomX Therapeutics (NASDAQ:CTMX) Given New $12.00 Price Target at Piper Sandler - MarketBeat

Mar 23, 2026

Mar 23, 2026

CTMX: Piper Sandler Raises Price Target to $12 | CTMX Stock News - gurufocus.com

Mar 23, 2026

Mar 23, 2026

Piper Sandler raises CytomX stock price target on drug trial data - Investing.com Canada

Mar 23, 2026

Mar 21, 2026

CytomX Therapeutics (CTMX) reports Q4 loss, misses revenue estimates - MSN

Mar 21, 2026

Mar 21, 2026

Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data - AOL.com

Mar 21, 2026

Mar 21, 2026

How Investors Are Reacting To CytomX Therapeutics (CTMX) Equity Raise And Encouraging Varseta-M Trial Data - Sahm

Mar 21, 2026

Mar 20, 2026

A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results - Yahoo Finance

Mar 20, 2026

Mar 20, 2026

Jefferies Raises CytomX Therapeutics (CTMX) Price Target to $16 - Insider Monkey

Mar 20, 2026

Mar 20, 2026

CytomX Therapeutics prices $250M public offering at $5.30 per share - MSN

Mar 20, 2026

Mar 20, 2026

CTMX Stock Pulls Back After 5-Year High: Share Sale Sparks Dilution Fears Despite Wall Street’s 150% Upside Calls - Stocktwits

Mar 20, 2026

Mar 20, 2026

Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing - marketscreener.com

Mar 20, 2026

Mar 20, 2026

CytomX Therapeutics SVP Belvin sells $202k in stock By Investing.com - Investing.com South Africa

Mar 20, 2026

Mar 19, 2026

Yu-Waye Chu Sells 21,279 Shares of CytomX Therapeutics (NASDAQ:CTMX) Stock - MarketBeat

Mar 19, 2026

Mar 19, 2026

Sean Mccarthy Sells 118,969 Shares of CytomX Therapeutics (NASDAQ:CTMX) Stock - MarketBeat

Mar 19, 2026

Mar 19, 2026

Sean McCarthy, CytomX Therapeutics CEO, sells $764k in stock By Investing.com - Investing.com Canada

Mar 19, 2026

Mar 19, 2026

CytomX therapeutics (CTMX) chief medical officer sells $136k in stock - Investing.com Canada

Mar 19, 2026

Mar 19, 2026

CytomX Therapeutics (NASDAQ:CTMX) CFO Sells $124,053.66 in Stock - MarketBeat

Mar 19, 2026

Mar 19, 2026

Insider Selling: CytomX Therapeutics (NASDAQ:CTMX) SVP Sells 31,492 Shares of Stock - MarketBeat

Mar 19, 2026

Mar 19, 2026

CytomX (CTMX) CMO sells 21,279 shares to cover RSU tax obligations - Stock Titan

Mar 19, 2026

Mar 19, 2026

Ogden, CytomX Therapeutics CFO, sells $124k in shares By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 19, 2026

CytomX Therapeutics SVP Belvin sells $202k in stock - Investing.com

Mar 19, 2026

Mar 19, 2026

CytomX Therapeutics (CTMX) CEO sells shares to cover RSU tax obligations - Stock Titan

Mar 19, 2026